Comments
Loading...

CVS Health Analyst Ratings

CVSNYSE
Logo brought to you by Benzinga Data
$67.09
At close: Jun 17 EDT
$66.86
-0.23-0.34%
Pre-Market: 7:35 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$100.00
Lowest Price Target1
$62.00
Consensus Price Target1
$80.08

CVS Health Analyst Ratings and Price Targets | NYSE:CVS | Benzinga

CVS Health Corp has a consensus price target of $80.08 based on the ratings of 26 analysts. The high is $100 issued by Morgan Stanley on November 2, 2023. The low is $62 issued by Cantor Fitzgerald on October 1, 2024. The 3 most-recent analyst ratings were released by Barclays, Truist Securities, and Wells Fargo on June 2, 2025, May 12, 2025, and May 6, 2025, respectively. With an average price target of $82.33 between Barclays, Truist Securities, and Wells Fargo, there's an implied 23.14% upside for CVS Health Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Mar
2
1
Apr
4
1
May
1
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Barclays
Truist Securities
Wells Fargo
RBC Capital
UBS

1calculated from analyst ratings

Analyst Ratings for CVS Health

Buy NowGet Alert
06/02/2025Buy Now18.16%Barclays
Andrew Mok57%
$82 → $79MaintainsOverweightGet Alert
05/12/2025Buy Now25.64%Truist Securities
David Macdonald65%
$82 → $84MaintainsBuyGet Alert
05/06/2025Buy Now25.64%Wells Fargo
Stephen Baxter53%
$76 → $84MaintainsOverweightGet Alert
05/05/2025Buy Now21.15%RBC Capital
Ben Hendrix60%
$74 → $81MaintainsOutperformGet Alert
05/02/2025Buy Now6.19%UBS
Kevin Caliendo71%
$67 → $71MaintainsNeutralGet Alert
05/02/2025Buy Now22.64%Barclays
Andrew Mok57%
$73 → $82MaintainsOverweightGet Alert
04/15/2025Buy Now6.19%Baird
Michael Ha38%
$51 → $71MaintainsNeutralGet Alert
04/11/2025Buy Now22.64%Truist Securities
David Macdonald65%
$76 → $82MaintainsBuyGet Alert
04/09/2025Buy Now13.67%Mizuho
Ann Hynes86%
$70 → $76MaintainsOutperformGet Alert
03/21/2025Buy Now10.68%Piper Sandler
Jessica Tassan38%
$72 → $74MaintainsOverweightGet Alert
02/18/2025Buy Now21.15%JP Morgan
Lisa Gill56%
$80 → $81MaintainsOverweightGet Alert
02/13/2025Buy Now9.18%Wells Fargo
Stephen Baxter53%
$68 → $73MaintainsOverweightGet Alert
02/13/2025Buy Now13.67%Truist Securities
David Macdonald65%
$60 → $76MaintainsBuyGet Alert
02/13/2025Buy Now9.18%Barclays
Andrew Mok57%
$71 → $73MaintainsOverweightGet Alert
02/13/2025Buy Now12.17%Leerink Partners
Michael Cherny78%
$55 → $75UpgradeMarket Perform → OutperformGet Alert
01/27/2025Buy Now-2.78%Evercore ISI Group
Elizabeth Anderson47%
$60 → $65MaintainsOutperformGet Alert
01/06/2025Buy Now-10.26%Truist Securities
David Macdonald65%
$67 → $60MaintainsBuyGet Alert
12/03/2024Buy Now-1.29%Deutsche Bank
George Hill60%
$66 → $66UpgradeHold → BuyGet Alert
11/25/2024Buy Now19.65%TD Cowen
Charles Ryhee50%
$73 → $80MaintainsBuyGet Alert
11/25/2024Buy Now-4.28%Piper Sandler
Jessica Tassan38%
$72 → $64MaintainsOverweightGet Alert
11/20/2024Buy Now0.21%Truist Securities
David Macdonald65%
$76 → $67ReiteratesBuy → BuyGet Alert
11/18/2024Buy Now-1.29%Wells Fargo
Stephen Baxter53%
$60 → $66UpgradeEqual-Weight → OverweightGet Alert
11/15/2024Buy Now-13.25%RBC Capital
Ben Hendrix60%
$68 → $58MaintainsOutperformGet Alert
11/07/2024Buy Now-7.27%UBS
Kevin Caliendo71%
$60 → $62MaintainsNeutralGet Alert
11/07/2024Buy Now6.19%Barclays
Andrew Mok57%
$75 → $71MaintainsOverweightGet Alert
11/04/2024Buy Now-10.26%Wells Fargo
Stephen Baxter53%
$61 → $60MaintainsEqual-WeightGet Alert
10/24/2024Buy Now-1.29%Mizuho
Ann Hynes86%
$73 → $66MaintainsOutperformGet Alert
10/23/2024Buy Now12.17%Barclays
Andrew Mok57%
$82 → $75MaintainsOverweightGet Alert
10/11/2024Buy Now13.67%Truist Securities
David Macdonald65%
$66 → $76MaintainsBuyGet Alert
10/10/2024Buy Now22.64%Barclays
Andrew Mok57%
$63 → $82UpgradeEqual-Weight → OverweightGet Alert
10/08/2024Buy Now12.17%Evercore ISI Group
Elizabeth Anderson47%
$62 → $75MaintainsOutperformGet Alert
10/04/2024Buy Now27.13%TD Cowen
Charles Ryhee50%
$59 → $85UpgradeHold → BuyGet Alert
10/01/2024Buy Now-7.27%Cantor Fitzgerald
Sarah James50%
$62 → $62ReiteratesNeutral → NeutralGet Alert
09/16/2024Buy Now-7.27%Cantor Fitzgerald
Sarah James50%
$62 → $62ReiteratesNeutral → NeutralGet Alert
09/10/2024Buy Now-7.27%Cantor Fitzgerald
Sarah James50%
$62 → $62ReiteratesNeutral → NeutralGet Alert
09/04/2024Buy Now1.71%RBC Capital
Ben Hendrix60%
$68 → $68ReiteratesOutperform → OutperformGet Alert
08/19/2024Buy Now-7.27%Cantor Fitzgerald
Sarah James50%
$62 → $62ReiteratesNeutral → NeutralGet Alert
08/12/2024Buy Now-8.76%Wells Fargo
Stephen Baxter53%
$60 → $61MaintainsEqual-WeightGet Alert
08/09/2024Buy Now-5.77%Deutsche Bank
George Hill60%
$64 → $63MaintainsHoldGet Alert
08/08/2024Buy Now-5.77%Barclays
Andrew Mok57%
$65 → $63MaintainsEqual-WeightGet Alert
08/08/2024Buy Now-7.27%Cantor Fitzgerald
Sarah James50%
$58 → $62MaintainsNeutralGet Alert
08/08/2024Buy Now-7.27%Evercore ISI Group
Elizabeth Anderson47%
$65 → $62MaintainsOutperformGet Alert
07/23/2024Buy Now-13.25%Cantor Fitzgerald
Sarah James50%
$58 → $58ReiteratesNeutral → NeutralGet Alert
06/12/2024Buy Now-13.25%Cantor Fitzgerald
Sarah James50%
$58 → $58ReiteratesNeutral → NeutralGet Alert
05/30/2024Buy Now28.63%JP Morgan
Lisa Gill56%
$101 → $86MaintainsOverweightGet Alert
05/30/2024Buy Now-8.76%Baird
Michael Ha38%
→ $61Initiates → NeutralGet Alert
05/08/2024Buy Now19.65%Argus Research
Chris Graja66%
$100 → $80MaintainsBuyGet Alert
05/07/2024Buy Now-10.26%Wells Fargo
Stephen Baxter53%
$76 → $60MaintainsEqual-WeightGet Alert
05/07/2024Buy Now-11.76%TD Cowen
Charles Ryhee50%
$99 → $59DowngradeBuy → HoldGet Alert
05/02/2024Buy Now15.17%B of A Securities
Michael Cherny78%
$95 → $77MaintainsBuyGet Alert
05/02/2024Buy Now10.68%Goldman Sachs
Nathan Rice56%
$85 → $74MaintainsBuyGet Alert
05/02/2024Buy Now-5.77%Barclays
Andrew Mok57%
$78 → $63MaintainsEqual-WeightGet Alert
05/02/2024Buy Now-10.26%UBS
Kevin Caliendo71%
$85 → $60DowngradeBuy → NeutralGet Alert
05/02/2024Buy Now-1.29%Truist Securities
David Macdonald65%
$90 → $66ReiteratesBuy → BuyGet Alert
05/02/2024Buy Now7.69%Mizuho
Ann Hynes86%
$86 → $72MaintainsBuyGet Alert
05/01/2024Buy Now-10.26%Leerink Partners
Michael Cherny78%
→ $60DowngradeOutperform → Market PerformGet Alert
05/01/2024Buy Now-13.25%Cantor Fitzgerald
Sarah James50%
$87 → $58DowngradeOverweight → NeutralGet Alert
04/10/2024Buy Now30.12%Cantor Fitzgerald
Sarah James50%
$87 → $87ReiteratesOverweight → OverweightGet Alert
04/08/2024Buy Now13.67%Wells Fargo
Stephen Baxter53%
$83 → $76MaintainsEqual-WeightGet Alert
04/04/2024Buy Now30.12%Cantor Fitzgerald
Sarah James50%
$87 → $87ReiteratesOverweight → OverweightGet Alert
03/15/2024Buy Now40.59%Piper Sandler
Jessica Tassan38%
$93 → $94MaintainsOverweightGet Alert
03/06/2024Buy Now16.66%Barclays
Andrew Mok57%
→ $78Initiates → Equal-WeightGet Alert
02/26/2024Buy Now31.62%Leerink Partners
Michael Cherny78%
→ $88Initiates → OutperformGet Alert
02/08/2024Buy Now30.12%Cantor Fitzgerald
Sarah James50%
$87 → $87ReiteratesOverweight → OverweightGet Alert
02/08/2024Buy Now25.64%RBC Capital
Ben Hendrix60%
$86 → $84MaintainsOutperformGet Alert
12/22/2023Buy Now40.59%HSBC
Daniela Bretthauer53%
→ $94Initiates → BuyGet Alert
12/11/2023Buy Now48.07%TD Cowen
Charles Ryhee50%
$102 → $99MaintainsOutperformGet Alert
11/21/2023Buy Now30.12%Cantor Fitzgerald
Sarah James50%
→ $87ReiteratesOverweight → OverweightGet Alert
11/02/2023Buy Now28.63%Mizuho
Ann Hynes86%
$88 → $86MaintainsBuyGet Alert
11/02/2023Buy Now28.63%RBC Capital
Ben Hendrix60%
$91 → $86MaintainsOutperformGet Alert
11/02/2023Buy Now49.57%Morgan Stanley
Erin Wright75%
$110 → $100MaintainsOverweightGet Alert
09/19/2023Buy Now24.14%Evercore ISI Group
Elizabeth Anderson47%
$81 → $83UpgradeIn-Line → OutperformGet Alert
09/14/2023Buy Now30.12%Cantor Fitzgerald
Sarah James50%
→ $87ReiteratesOverweight → OverweightGet Alert
09/12/2023Buy Now19.65%Wolfe Research
Justin Lake32%
→ $80UpgradePeer Perform → OutperformGet Alert
09/01/2023Buy Now22.64%Piper Sandler
Jessica Tassan38%
$85 → $82MaintainsOverweightGet Alert
08/18/2023Buy Now36.11%RBC Capital
Ben Hendrix60%
→ $91ReiteratesOutperform → OutperformGet Alert
08/18/2023Buy NowEdward Jones
Ashtyn Evans1%
DowngradeBuy → HoldGet Alert
08/04/2023Buy Now27.13%Raymond James
John Ransom76%
$90 → $85MaintainsOutperformGet Alert
08/03/2023Buy Now46.57%Truist Securities
David Macdonald65%
$103 → $98MaintainsBuyGet Alert
08/03/2023Buy Now64.52%Morgan Stanley
Erin Wright75%
$120 → $110MaintainsOverweightGet Alert
08/03/2023Buy Now36.11%RBC Capital
Ben Hendrix60%
$102 → $91MaintainsOutperformGet Alert
08/03/2023Buy Now28.63%Barclays
Steve Valiquette52%
$89 → $86MaintainsOverweightGet Alert
07/12/2023Buy Now33.11%Barclays
Steve Valiquette52%
$90 → $89MaintainsOverweightGet Alert
07/11/2023Buy Now31.62%Mizuho
Ann Hynes86%
$120 → $88MaintainsBuyGet Alert
07/07/2023Buy Now58.54%JP Morgan
Lisa Gill56%
$114 → $106MaintainsOverweightGet Alert
06/20/2023Buy Now54.05%Truist Securities
David Macdonald65%
$109 → $103MaintainsBuyGet Alert
05/30/2023Buy Now70.51%JP Morgan
Lisa Gill56%
$125 → $114MaintainsOverweightGet Alert
05/26/2023Buy Now27.13%Piper Sandler
Jessica Tassan38%
→ $85Initiates → OverweightGet Alert
05/09/2023Buy Now52.56%RBC Capital
Ben Hendrix60%
→ $102Reiterates → OutperformGet Alert
05/08/2023Buy Now13.67%Wells Fargo
Stephen Baxter53%
$95 → $76MaintainsEqual-WeightGet Alert
05/08/2023Buy Now43.58%Credit Suisse
A.J. Rice70%
$125 → $96MaintainsOutperformGet Alert
05/08/2023Buy Now34.61%Raymond James
John Ransom76%
$110 → $90MaintainsOutperformGet Alert
05/05/2023Buy Now31.62%Goldman Sachs
Nathan Rice56%
$100 → $88MaintainsBuyGet Alert
05/04/2023Buy Now31.62%Goldman Sachs
Nathan Rich42%
$100 → $88MaintainsBuyGet Alert
05/04/2023Buy Now34.61%Barclays
Steve Valiquette52%
$100 → $90MaintainsOverweightGet Alert
05/02/2023Buy Now40.59%UBS
Kevin Caliendo71%
$102 → $94MaintainsBuyGet Alert
05/02/2023Buy Now39.1%Bernstein
Lance Wilkes54%
$107 → $93MaintainsMarket PerformGet Alert
04/21/2023Buy Now30.12%Cantor Fitzgerald
Sarah James50%
→ $87Initiates → OverweightGet Alert
04/18/2023Buy Now66.02%TD Cowen
Charles Ryhee50%
$118 → $111MaintainsOutperformGet Alert
03/31/2023Buy Now55.55%B of A Securities
Michael Cherny78%
$111 → $104MaintainsBuyGet Alert

FAQ

Q

What is the target price for CVS Health (CVS) stock?

A

The latest price target for CVS Health (NYSE:CVS) was reported by Barclays on June 2, 2025. The analyst firm set a price target for $79.00 expecting CVS to rise to within 12 months (a possible 18.16% upside). 43 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for CVS Health (CVS)?

A

The latest analyst rating for CVS Health (NYSE:CVS) was provided by Barclays, and CVS Health maintained their overweight rating.

Q

When was the last upgrade for CVS Health (CVS)?

A

The last upgrade for CVS Health Corp happened on February 13, 2025 when Leerink Partners raised their price target to $75. Leerink Partners previously had a market perform for CVS Health Corp.

Q

When was the last downgrade for CVS Health (CVS)?

A

The last downgrade for CVS Health Corp happened on May 7, 2024 when TD Cowen changed their price target from $99 to $59 for CVS Health Corp.

Q

When is the next analyst rating going to be posted or updated for CVS Health (CVS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CVS Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CVS Health was filed on June 2, 2025 so you should expect the next rating to be made available sometime around June 2, 2026.

Q

Is the Analyst Rating CVS Health (CVS) correct?

A

While ratings are subjective and will change, the latest CVS Health (CVS) rating was a maintained with a price target of $82.00 to $79.00. The current price CVS Health (CVS) is trading at is $66.86, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch